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Background: Patch-based approaches to regenerating damaged myocardium include
epicardial surgical transplantation of heart patches. By the time this therapy is ready
for widespread clinical use, it may be important that patches can be delivered via
minimally invasive and robotic surgical approaches. This brief research report describes
a world-first minimally invasive patch transplantation surgical device design enabled for
human operation, master-slave, and fully automated robotic control.
Method: Over a 12-month period (2019–20) in our multidisciplinary team we designed
a surgical instrument to transplant heart patches to the epicardial surface. The device
was designed for use via uni-portal or multi-portal Video-Assisted Thorascopic Surgery
(VATS). For preliminary feasibility and sizing, we used a 3D printer to produce parts of a
flexible resin model from a computer-aided design (CAD) software platform in preparation
for more robust high-resolution metal manufacturing.
Results: The instrument was designed as a sheath containing foldable arms, <2 cm
in diameter when infolded to fit minimally invasive thoracic ports. The total length was
35 cm. When the arms were projected from the sheath, three moveable mechanical
arms at the distal end were designed to hold a patch. Features included: a rotational
head allowing for the arms to be angled in real time, a surface with micro-attachment
points for patches and a releasing mechanism to release the patch.
Conclusion: This brief research report represents a first step on a potential pathway
towards minimally invasive robotic epicardial patch transplantation. For full feasibility
testing, future proof-of-concept studies, and efficacy trials will be needed.
Keywords: instrumentation, regeneration, thorascopic surgery, myocardial patch, automation, keyhole, chest
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GRAPHICAL ABSTRACT |
INTRODUCTION
Since the first reports of robotic minimally invasive cardiac
surgery (1), there has been increasing attention given to the
role of minimally invasive robotics in cardiothoracic surgery
(2–6). Meanwhile, tissue engineers have been making gains
toward regenerating the myocardium (7–9). The first human
trials of patches containing biomaterials/cells applied to the
epicardial surface to regenerate the heart have been reported
with promising results (10–14). Moreover, increasingly accessible
techniques such as 3D bioprinting (one approach to generating
heart tissue patches) promise scalability, reproducibility, and
highly refined control over the characteristics of the patch to
be grafted (7). However, many approaches to regenerate the
myocardium surgically using patches applied to the epicardial
surface have worked toward a model of open surgery via median
sternotomy (8). There is an unanswered but pressing question
whether surgical patch-based repair of the heart will need to be
delivered by minimally invasive and/or robotic surgery by the
time it reaches widespread clinical use (7). Additionally, for heart
failure patients who may not be fit for a heart transplant or major
surgery but who may tolerate a less invasive keyhole procedure
(15), this solution may open up a therapeutic avenue for them.
Our team therefore conceptualised and designed a
novel surgical instrument to deliver heart tissue patches
to the epicardium. Our multidisciplinary team included a
cardiothoracic surgeon, a bioengineer and two specialists in
robotics, mechanical engineering, and mechatronics. To our
knowledge, the early-stage design we present is a world-first
with no similar design existing. This descriptive brief research
report represents the initial step on a potentially significant
pathway to pivot the field away from its focus on traditional
open surgery.
METHOD
Design Process, Objectives, Reasoning
The design process was initiated with several discussions
amongst the team to determine the objectives, requirements,
and feasibility of the idea. An initial outline of the design was
sketched with attention to the ergonomics at human surgery,
the size and material requirements for thorascopic insertion and
manipulation of the instrument within the chest cavity, the shape
requirements to ensure suitability for human cardiothoracic
anatomy, the mechanism to allow for an operator to manoeuvre
the instrument using handles outside the chest cavity at the
proximal (external) end of the instrument and the ability for the
device to be controlled in future by both master-slave robotics
and fully automated robotics.
Using SOLIDWORKS R© (Dassault Systèmes SOLIDWORKS
Corp, Waltham, MA, USA) computer aided design (CAD)
software, the instrument blueprint was created and revised
several times to ensure it was optimised. At this stage, attention
was given to the points of attachment for patches onto the
instrument and the details of how the patch would fold into
the instrument when retracted and then be spread out for
deployment when expanded (without damaging the patch).
Another challenge was the releasing mechanism for the patch
to release it from the instrument. It was decided that tiny
attachment nodules/hooks would be placed at the distal ends of
the manoeuvrable arms and at the apex of the pyramid created
by the three arms converging. When the arms are expanded
(outfolded) this stretches out the patch between the metal arms.
This has the effect that when outstretched the patch itself would
move away from the apex and fold out to form the base of
a pyramid.
The patches will be made from alginate 4%/gelatin 8%
in cell culture medium, which is a hydrogel that becomes
fluid at temperatures over ∼28◦C and is more solid at lower
temperatures. It can be crosslinked ionically by adding calcium
chloride (2% w/v in phosphate buffered saline) which increases
the strength of the material. A similar hydrogel with a modified
molecular structure, gelatin methacryloyl (GelMA), can be used
in a similar way to alginate/gelatin but is more robust when it is
crosslinked which is done by UV light photocuring. Therefore,
we created the instrument design to include areas for attachment
nodules/hooks which would be attached to areas within the patch
containing small rings of GelMA at the corners and the centre.
These reinforced patch ring-corners would be attached to the
arms distally. In the folded position, the patch centre will be
similarly attached to the instrument platform where the proximal
ends of the three arms converge (the apex of the pyramid
formed by the arms). When opening the arms (pitch rotational
movement) this will pull the patch away from the platform where
the proximal ends of the arms converge as it unfolds and expands
to become the outstretched base of the pyramid. Next, to release
the three patch corners from the apex, the instrument arms can
be moved laterally (yaw rotational movement). To ensure that
release happens first at the apex/central connection the strength
of the GelMA ring will be modified by using fewer layers so that
this connection releases first (before the GelMA ring connection
to the distal tips of the arms). In case of failure to release by
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FIGURE 1 | (A,B) Lateral view. One single Grip (GP) controls forward protrusion and backwards retraction of the instrument. Grips G1–G3 are triplicate (only two of
each are visible in the 2D lateral view images shown), and control each of the three distal arms to which they are attached (distal arms not visible - infolded and
covered by sheath). G3 Grips control the curvature of the patch, G2 the rotation angle of the arm, and G1 the deployment angle of the arm. (C) “Top down” view
showing triplicate arrangement of Grips when in line with each other and opened with 120 degree angles between each set of three Grips. Grips exit the cylindrical
instrument body which has diameter of 15 mm. All measurements in mm. See Supplementary Video 1 for dynamic demonstration in silico.
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this mechanism, the platforms with the hook/nodule attachments
can be moved in a sliding movement distally away from the
instrument body, theoretically releasing them by breaking the
GelMA rings.
The head has a rotational mechanism (role rotational
movement) which allows for the rotation of the patch through
360 degrees. One arm is able to be made shorter than the
other two during patch deployment. This means that by opening
that arm past 90 degrees to the main instrument body whilst
shortening it, the patch should be able to open and face any
lateral direction (similar to the triangle that can be made with the
extended index and middle finger to the thumb in opposition).
This gives the instrument three degrees of rotational movement
in addition to the three degrees of translational movement in
the X, Y, and Z axis which are achieved by movements at the
entry into the chest (similar to moving a pencil pinched lightly
between the thumb and index finger). Additional to these six
degrees of freedom, each arm is capable of pitch and yaw rotation
individually. The shortenable arm has the additional benefit of
being openable in a confined space, for example, if facing the
surface of the heart when opening, so that its excursionary
movement can be completed without damaging surrounding
structures. Overall, thesemovements will allow for the patch to be
expanded in the hemithorax and then rotated to face the surface
of the heart at the correct angle.
One surgical approach for the operation of this instrument
is via standard left-sided anterolateral multiportal video-assisted
thorascopic surgery (VATS)—similar to a left lower lobectomy
approach but with the left lung deflated via endobronchial
intubation and single lung ventilation of the right lung. The
pericardium would need to be partly opened to gain access
to the epicardial surface. In particular, for a chronic ischaemic
cardiomyopathy heart failure patient or after myocardial
infarction (MI), the target area may be the anterolateral surface
of the heart over the left ventricle. With the rotational head and
the releasing mechanism, it should be possible to manoeuvre
the patch and apply it to the epicardium on most surfaces
reachable without moving the heart: a minimally invasive VATS
transplantation of a regenerative cardiac patch.
Following these discussions and revisions aimed at optimising
the instrument design we 3D printed a version of the instrument
to assess for size and identify learning points. This “sizing and
learning” print was in preparation for the full metal prototyping
which will use 17-4 Ph Stainless Steel (SAE Type 630 stainless




The device has nine Grips plus one push-out Grip (Figure 1,
Supplementary Video 1). Each arm has three Grips (Figure 1A,
Labels G1, G2, and G3). The top Grip (G3) controls the
attachment platforms and therefore the curvature of the patch
(it also acts as a releasing mechanism if attachment platforms are
moved beyond the maximal boundary of the outfolded patch),
the middle Grip (G2) controls the rotation angle of the arm, and
the bottom Grip (G1) controls the deployment angle of the arm.
The push out Grip (GP) protracts or retracts the arms from their
sheath. Supplementary Figure 1 shows a frontal and trimetric
view of the mechanism with the sheath removed.
The designed length of the instrument was 35 cm and cylinder
diameter was 1.5 cm (Figures 1B,C). Each arm was 60mm, thus
the maximum size of a triangular outfolded patch would be ∼18
cm2. The tips of each arm are 11.2 cm apart while opened at
90 degrees to the body of the instrument. The smallest parts in
our instrument were the joints which are cylindrical type joins
(which act like screws connecting two linked pieces) and these
were 1mm diameter and 1 mm height.
Special features of the instrument included a space between
the arms when infolded where the folded patch could be stored
prior to deployment (Figure 2). The patch could therefore be
inserted into the chest within the mechanism (and covered by
the outer sheath) without damaging it during insertion. Control
over each of the three arms was achieved by three separate
mechanisms connecting the arms to the Grips at the proximal
end of the device (Supplementary Figure 2).
The arms were designed so that they could be individually
rotated, including when the arms are folded out from their closed
position. The region conveying rotationary control is shown
in Supplementary Figure 3. In Supplementary Figure 3B the
proximal (operator’s end) region where the Grips converge
is shown.
Along each arm the design includes a moveable attachment
platform which can be controlled using Grip number 3
(control pathway highlighted in Supplementary Figure 2A).
Supplementary Video 1 shows the releasing mechanism as it
moves along one of the three arms. This movement from the
distal aspect of an arm to the proximal aspect allows for the
attachment platforms to be moved, pulling them away from
the patch connections and releasing the patch. These patch
connecting platforms are shown in more detail in Figure 3.
The attachment platforms will have small hooks (not shown
in the figure) where they will be able to attach to rings of a
semi-robust crosslinked hydrogel (GelMA) at the corners of the
patch. If the releasing mechanism fails to move the hook from
the patch and release that corner, the arm could be rotated using
the rotationary mechanism shown in Supplementary Figure 3
to pull the connection away from the patch. To reduce the risk
of injury to surrounding structures, the edges of the design are
curved and smooth (Figure 4).
3D Printing of Sizing and Learning Resin
Prototype
Some of the parameters for the 3D printer settings for the sizing
and learning prototype are shown in Supplementary Figure 4.
We used a Stratasys J750TM polyjet multi-material 3D printer
(Stratasys, Eden Prairie, MN, USA). The materials used to print
the test (sizing and learning) prototype parts were VeroVivid (a
translucent colour material) and Agilus (an elastomeric polymer)
which cost under £10 GBP ($14 USD). The total cost (excluding
hardware purchase) of the sizing and learning print was <£60
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FIGURE 2 | (A,B) Close-up angled view (A) and complete lateral view (B) of the distal end of the instrument (the patient end where the patch would be enclosed).
Movements of this compartment are controlled at the other (operator’s) end of the instrument by the connected Grips shown in Figure 1.
GBP ($83 USD). A comparison of the resin size to the computer-
aided design blueprint is shown in Figure 4. The printed product
underwent a chemical bath (in a solvent named Opteon SF-79,
which is used to dissolve the support material for the printed
parts) and during this final phase some of the tiny cylinder joints
(6 out of 13) were lost.
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FIGURE 3 | The patch releasing mechanism in close-up. (A) Shows an arm patch attachment point/platform (highlighted in blue); (B) shows anterior view close-up of
the platform where a hook/nodule (not shown) will attach patch corners; (C) shows a posterior view of the platform shown in (B).
DISCUSSION
Brief Research Report key Considerations
and Unanswered Questions
Our novel surgical instrument design is aimed at minimally
invasive approaches to transplant patches for myocardial
regeneration and is enabled for future robotic control of the
device. Whilst it has not been designed to fit with current
commercially available cardiothoracic surgical robots, it has been
designed to be ready for robotic control, where the instrument
itself would be attached as a forearm to a robotic arm. This
was based on the capabilities in our department to build a full
robotic arm and the instrument could be used for master-slave
or full automation. It is important that any new instrument
design is enabled for compatibility to these envisaged future
robotic controls.
The sizing and learning resin 3D print gave several insights
which will be invaluable for the full prototyping phase from
stainless steel. Firstly, it showed us that a major challenge is going
to be accounting for the manufacturing machine error with such
small parts (our smallest components are 1mmdiameter× 1mm
height cylinder joints). The printer we used has a high resolution
(horizontal build layers down to 14µm) but there is also print
error margin of ±150–200 µm (up to 1% of the diameter of our
instrument and 20% of our 1 mm cylinder joints). These valuable
learning points taught us that the next phase will likely require
both a slight enlarging of the instrument and also the use of a
very low error manufacturing technique for the stainless steel
prototype. Furthermore, each part in the design is a perfect fit
and therefore allowed no space for collision volume (the distance
away from the molecular centre which may come into contact
with adjacent parts). The metal print in future will require micro-
adjustments across every part of the design to add ±100 µm
space around each part so that there is room for manufacturing
machine error in the generation of the stainless steel prototype.
Another consideration is that following the initial fabrication
of the instrument it will have to be immersed in the same
chemical bath used for the resin sizing and learning print
(Opteon SF-79) during which time our tiny joints can still be lost.
In fact, during the resin learning print 6 of our 13 joints were lost
during the chemical bath. Therefore, wemay need to include over
20, adding in extra joints in anticipation that some will be lost
during the manufacturing process. Future trials by our group will
determine whether these issues can be minimised by increasing
the size of the instrument without removing the clinical utility.
We have envisaged the instrument being used for VATS
approaches and it should be highly versatile so it can be used with
multiple surgical approaches via uniportal (one large “keyhole”
in the chest for all instruments) or multiportal (several keyhole
incisions) VATS—for example with a left anterolateral approach.
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FIGURE 4 | Curved edges of the arm to reduce risk of injury to surrounding structures inside the chest. (A) Shows the CAD blueprint for the main component of one
of the arms. The photographs in (B,C) show the same curved edged arm with surrounding component parts after the sizing and learning resin print (VeroVivid and
Agilus). These parts were reproduced with a high degree of accuracy to the blueprint and the surrounding component parts fitted with the main body of the arm. This
(Continued)
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FIGURE 4 | suggests these components will be accurately fabricated in the subsequent stainless steel prototype. Photographs in (D,E) show component parts
outcome of Agilus/VeroVivid resin sizing and learning print. Despite inherent printer error margin, sizes were accurate to the CAD blueprint and appropriate for surgical
use. There were limitations to the resolution printable by this method shown by the fusion of resin material at the distal tip in the photograph (F) compared to the input
CAD image shown in (G). This has shown that subsequent prototyping will require a manufacturing method capable of retaining the detail of small parts within the
device.
The exact approach would depend on the target area of the heart
(for instance we would probably want to deploy the patch over
a specific infarcted or failing area of the left ventricle). This will
likely need a wide space andmultiple ports to get a good view and
manoeuvre into the best position.
The patch itself (see Supplementary Video 1) can be
customised in many ways with different biomaterials to control
the viscosity of the patch and also for different cell types within
the patch (16). Many different cells have been tried by researchers
in this field, often derived from stem cells (7). Our approach
might be able to treat heart failure for patients who would
otherwise not be eligible for a transplant (in a less invasive
standalone procedure to patch the myocardium rather than
replace the whole heart). There are many complex considerations
for this, including whether one could generate a patch of patient-
specific heart tissue from stem cells reprogrammed from the
patient’s own skin cells and transplant that (7). Importantly,
all approaches to myocardial regeneration with a patch
have so far have imagined an open surgical transplantation
method which may actually preclude this treatment in
many of the heart failure patients it is ultimately intended
to benefit.
The therapeutic approach will be different for the acute vs.
chronic phase of ischaemic cardiomyopathy and/or MI and
initially this instrument has been designed with a view to being
applicable in a non-acute situation as a standalone procedure. In
the acute phase it may not even be required to transplant cells
but just putting a patch as an adjunct to regular treatment which
stimulates macrophages and other inflammatory responses may
be beneficial for remodelling and cardiac function after MI (17).
For this instrument, it is clinically most likely to be useful for
chronic heart failure caused by ischaemia or MI. There are many
open questions and a large amount of research is focused on
regenerating the myocardium (7, 8). The unique selling point
of this instrument is that no one has yet presented a solution to
the question of how to transplant patches without open surgery.
By the time regenerative patches for the myocardium are ready
for clinical use they may need to be able to be transplanted by
minimally invasive and/or robotic approaches. If patch transplant
were to be used as an adjunct in a patient already undergoing
another procedure, a minimally invasive method would need to
exist because the primary procedure may not be via open surgery.
As a standalone treatment for high-risk patients with heart failure
who cannot have open surgery, it may be beneficial for them if
this can be done by a less invasive approach.
This brief research report represents the first time this
approach has been presented (without restriction for anyone
to build upon). Whilst it has been developed for cardiac
applications, it could even be co-opted for other applications
(e.g. abdominopelvic) where diverse minimally invasive robotic
approaches are also being developed (5, 6). Its main limitation is
that the descriptive work herein is at an early stage. It is likely
that future instrument designs will have to be larger, perhaps
more fitting for a 5–6 cm incision rather than a 2 cm one. This
would also have the potential benefit of bypassing the major
challenge of how to infold a patch then outfold it like a net
(without crushing it). Specifically, a 5–6 cm diameter instrument
could potentially accommodate a non-folded patch large enough
to be used without repeated application of small patches. Future
studies will be needed to optimise designs, fully prototype them
and then assess the actual performance of any prototype in
proof-of-concept surgery followed by full ex-vivo (cadaver) and
in-vivo trials. Efficacy will need to be evaluated in terms of
transplantation success over repeated applications (with full
measurement of parameters such as time to delivery, deployment
accuracy in a non-beating and beating heart, patch size, covered
epicardial surface area and a full range of quantitative and
qualitative analyses—all compared to relevant controls). Then
trials will be needed for a functional demonstration of a clinically
and statistically significant improvement in cardiac function
(including non-inferiority against the alternative approach of
traditional open surgery). Whilst this brief report article has
focused on a surgical instrument design, significant work will
also be needed to show that the patch matrix we propose—
alginate 4%/gelatin 8% patches ± cells based on our previous
optimisation for cardiac applications (9, 16, 18)—is superior to
reference patch materials. Translating these technologies is a
lengthy process, which is part of the point: it should happen in
parallel to the advancements currently underway in the field of
myocardial regeneration, or the field risks unveiling a successful
new treatment to a world that might have moved away from
traditional open surgery (2, 19), limiting how to actually deliver it.
CONCLUSION
Over 12months our multidisciplinary team has invented a design
for a novel surgical instrument which is at the leading edge of
innovation in this field. Findings from our sizing and learning
resin print of this instrument have prepared the way for the
stainless-steel prototype to be manufactured. This is a world-
first achievement which may alter the direction of research for
surgical transplantation of patches for myocardial regeneration.
This brief research report presents the first step on this pathway,
for which further trials will be needed.
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Supplementary Figure 1 | The instrument with the sheath covering the distal
arms removed. Frontal (A) and trimetric (B) views show the instrument with arms
in the infolded position.
Supplementary Figure 2 | Control pathways linking the operator’s end to the
distal arms. (A–C) Highlighted views of the three Grips controlling the distal arms.
Supplementary Figure 3 | Mechanism allowing for adjustment of the rotational
angle of the arms. Infolded arms (A) can be outfolded to open position and
rotated individually by the grips shown in (B). View shown in (A) is the distal
(patient’s end) and (B) shows a “top down” view of the proximal (operator’s end) of
the instrument (looking down onto the Grips).
Supplementary Figure 4 | 3D printing parameters for the resin sizing and
learning prototyping of individual parts.
Supplementary Video 1 | Video walkthrough of patch delivery device, including
background and mechanistic demonstration from the computer-aided
design (CAD).
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